Toggle Offcanvas
...
Global Government Tenders

Most trusted source for Tendering Opportunities and Business Intelligence since 2002

Information On The Entering Into Amgros' License Agreement For The Medicinal Product Adzynma (Apadamtase Alfa And Cinaxadamtase Alfa)

Amgros I S Denmark has Released a tender for Information On The Entering Into Amgros' License Agreement For The Medicinal Product Adzynma (Apadamtase Alfa And Cinaxadamtase Alfa) in Pharmaceuticals. The tender was released on Feb 07, 2025.

Country - Denmark

Summary - Information On The Entering Into Amgros' License Agreement For The Medicinal Product Adzynma (Apadamtase Alfa And Cinaxadamtase Alfa)

Deadline - Feb 06, 2026

GT reference number - 102852082

Product classification - Pharmaceutical products

Organization Details:

  Address - Denmark

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 102852082

  Document Type - Tender Notices

Notice Details and Documents:

Description - Description: This advance notice is an information about Amgros’ expected conclusion of commissioning agreements for covered medicinal products in section 3.1.Amgros will enter into commissioning agreements with all interested parties, and Amgros t herefore encourages all potential entrants to enter into Amgros’ commissioning agreements for the medicinal products below to express interest by sending relevant information including price to udbu@amgros.dk. Amgros expects to offer the covered medicinal products as framework agreements in a public tender at a later date, and the expectation is that the tender will be published within the next 12 months, but this will depend on several factors

Gt Ref Id - 102852082

Deadline - Feb 06, 2026

Share share

Similar Tenders :

Create Account

Why Us

3,00,000 +

Users

190 +

Countries Covered

5,00,000 +

Agencies Tracked

50,000 +

Notices Daily

90 Million +

Database